节点文献

脂肝消丸治疗脂肪肝的临床研究

Clinical Study on the Therapeutic Effect of Zhigan Xiaowan on the Patients with Fatty Liver

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 彭立生贺劲松周大桥高辉童光东陈亮

【Author】 Peng Lishen,He Jingsong,Zhou Daqiao,Gao Hui. Hepatopathy Institute,Shenzhen TCM Hospital Attached to Guangzhou TCM University

【机构】 广州中医药大学附属深圳中医院肝病重点专科

【摘要】 目的:探讨脂肝消丸对脂肪肝的临床疗效。方法:选择脂肪肝患者148例,随机分为治疗组86例、对照组62例,治疗组口服脂肝消丸,对照组服用绞股蓝总苷片、维生素E,观察治疗后的总有效率、肝功能及血脂的变化。结果:经治疗后治疗组总有效率优于对照组(P<0.05);患者ALT、AST和GGT均明显降低,且优于对照组(P<0.05或0.01);同时TCh、TG及LDL较治疗前显著降低(P<0.05或0.01),HDL较治疗前明显升高(P<0.05),其中TCh、TG明显较对照组为优(P<0.05)。结论:脂肝消丸治疗脂肪肝疗效显著,能明显改善肝功能、降低血脂。

【Abstract】 Aim:To evaluate the clinical curative effects of Zhigan Xiaowan for treating fatty liver.Methods:148 patients with fatty liver were divided into two groups randomly,the therapeutic group 86,treated by the Zhigan Xiaowan,the control group 62,treated by Jiaogulan Tablet and VitE. After treatment,total efficiency rate,the indexes of liver function and the level of blood lipid were detected.Results:The total efficiency rate of the therapeutic group was better than that of control group(P<0.05).ALT,AST and GGT were obviously decreased and better than that of control group (P<0.05 or 0.01).Meanwhile,the level of TCh、TG and LDL were lowered markedly,and the level of HDL were enhanced after treatment(P<0.05 or 0.01).There was significant difference on TCh and TG between the two groups(P<0.05).Conclusion:The curative effect of Zhigan Xiaowan was marked on fatty liver.It can regulate liver functions and decrease blood lipid obviously.

【关键词】 脂肪肝脂肝消丸临床研究
【Key words】 Fatty LiverZhigan XiaowanClinical Study
  • 【会议录名称】 中华中医药学会第十二届内科肝胆病学术会议暨第四次国家中医肝病重点专科协作组学术会议论文汇编
  • 【会议名称】中华中医药学会第十二届内科肝胆病学术会议暨第四次国家中医肝病重点专科协作组学术会议
  • 【会议时间】2006-05-01
  • 【会议地点】中国广州深圳
  • 【分类号】R259
  • 【主办单位】中华中医药学会内科肝胆病学术委员会、国家中医肝病重点专科协作组
节点文献中: 

本文链接的文献网络图示:

本文的引文网络